CITIUS PHARMACEUTICALS INC.

- USD (-)

- 15 min delayed data - NASDAQ Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	CTXR
ISIN:

CITIUS PHARMACEUTICALS INC. overview

> Analyses

Londinia AI has published a new analysis for 3ba0550.

0
90358
15539
0

CITIUS PHARMACEUTICALS INC. - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on CITIUS PHARMACEUTICALS INC. as long as the price remains well above 1.32…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for 3ba0550.

0
90358
15539
0

CITIUS PHARMACEUTICALS INC. - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

The bullish trend is currently very strong on CITIUS PHARMACEUTICALS INC.. As long as the price remains above the support at 1.32 USD, you could try to benefit from the boom. The first bullish…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for 3ba0550.

0
90358
15539
0

CITIUS PHARMACEUTICALS INC. - 15 min.

Timeframe : 15 min. - Simple chart
Status : TARGET REACHED

Thank you Reply Chart

> News ACCESSWIRE published a news.

Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City • • ACCESSWIRE • Stocks • More CITIUS PHARMACEUTICALS INC. news...

NEW YORK, NY / ACCESSWIRE / March 3, 2020 / Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), is a specialty pharmaceutical company dedicated to the development and commercialization of drug products that address important unmet medical needs, will be presenting at this year's Spring Investor Summit on March 25th-26th in New York City. The Spring Investor Summit will take place at the Essex House, featuring 100 companies and over 500 institutional and retail investors. About Citius Pharmaceuticals,...

Thank you Chart

> News Newsfile Corp. published a news.

Biotech Companies Think Big with Specialization - Fighting Deadly Bacteria and Viruses • • Newsfile Corp. • Stocks • More CITIUS PHARMACEUTICALS INC. news...

Point Roberts, Washington and Vancouver, British Columbia--(Newsfile Corp. - January 27, 2020) - Investorideas.com , a leading investor news resource covering pharmaceutical and biotechnology stocks releases a special report on the opportunity within the specialty drug segment of the sector to address viral outbreaks and bacterial resistance, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR). Read the full article on Investorideas.com...

Thank you Chart

Load more content

Market scanning tools

See all Signals

Statistics

Analyses : 21
Followers : 0